DNLI  Denali Therapeutics Inc.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ

Denali Therapeutics Inc., is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis (ALS). The Company is developing a diversified portfolio of therapeutics, based on scientific insights into the genetic causes and biological processes underlying neurodegenerative disease. The Company has selected approximately three specific pathways that are implicated as triggers or effectors of neurodegeneration, including degenogenes (genes that cause neurodegenerative disease when mutated), defective intracellular trafficking, glial dysfunction and axon degeneration.